Abstract
Microbes are an integral part of life on this planet. Microbes and their hosts influence each other in an endless dance that shapes how the meta-organism interacts with its environment. Although great advances have been made in microbiome research over the past 20 years, the mechanisms by which both hosts and their microbes interact with each other and the environment are still not well understood. The nematode Caenorhabditis elegans has been widely used as a model organism to study a remarkable number of human-like processes. Recent evidence shows that the worm is a powerful tool to investigate in fine detail the complexity that exists in microbe–host interactions. By combining the large array of genetic tools available for both organisms together with deep phenotyping approaches, it has been possible to uncover key effectors in the complex relationship between microbes and their hosts. In this perspective, we survey the literature for insightful discoveries in the microbiome field using the worm as a model. We discuss the latest conceptual and technological advances in the field and highlight the strengths that make C. elegans a valuable biosensor tool for the study of microbe–host interactions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tashiro, T. et al. Early trace of life from 3.95 Ga sedimentary rocks in Labrador, Canada. Nature 549, 516–518 (2017).
Foster, K. R., Schluter, J., Coyte, K. Z. & Rakoff-Nahoum, S. The evolution of the host microbiome as an ecosystem on a leash. Nature 548, 43–51 (2017).
Groussin, M. et al. Unraveling the processes shaping mammalian gut microbiomes over evolutionary time. Nat. Commun. 8, 14319 (2017).
Sharpton, T. J. Role of the gut microbiome in vertebrate evolution. mSystems 3, e00174-17 (2018).
Louca, S. et al. Function and functional redundancy in microbial systems. Nat. Ecol. Evol 2, 936–943 (2018).
Klassen, J. L. Defining microbiome function. Nat. Microbiol. 3, 864–869 (2018).
Skillings, D. Holobionts and the ecology of organisms: multi-species communities or integrated individuals? Biol. Philos. 31, 875–892 (2016).
Hammer, T. J., Sanders, J. G. & Fierer, N. Not all animals need a microbiome. FEMS Microbiol. Lett. 366, 1–11 (2019).
Lloyd-Price, J., Abu-Ali, G. & Huttenhower, C. The healthy human microbiome. Genome Med. 8, 1–11 (2016).
Gonze, D., Lahti, L., Raes, J. & Faust, K. Multi-stability and the origin of microbial community types. ISME J. 11, 2159–2166 (2017).
Martí, J. M. et al. Health and disease imprinted in the time variability of the human microbiome. mSystems 2, e00144-16 (2017).
D’hoe, K. et al. Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community. Elife 7, 299644 (2018).
Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
Brochado, A. R. et al. Species-specific activity of antibacterial drug combinations. Nature 559, 259–263 (2018).
Douglas, A. E. Simple animal models for microbiome research. Nat. Rev. Microbiol. 17, 764–775 (2019).
Stagaman, K., Sharpton, T. J. & Guillemin, K. Zebrafish microbiome studies make waves. Lab Anim. (NY) 49, 201–207 (2020).
Norvaisas, P. & Cabreiro, F. Pharmacology in the age of the holobiont. Curr. Opin. Syst. Biol. 10, 34–42 (2018).
Frézal, L. & Félix, M.-A. C. elegans outside the Petri dish. Elife 4, 1–14 (2015).
Zhang, F. et al. Caenorhabditis elegans as a model for microbiome research. Front. Microbiol. 8, 485 (2017).
Kim, W. et al. A new class of synthetic retinoid antibiotics effective against bacterial persisters. Nature 556, 103–107 (2018).
Qi, B. & Han, M. Microbial siderophore enterobactin promotes mitochondrial iron uptake and development of the host via interaction with ATP synthase. Cell 175, 571–582.e11 (2018).
Seth, P. et al. Regulation of microRNA machinery and development by interspecies S-nitrosylation. Cell 176, 1014–1025.e12 (2019).
Dirksen, P. et al. The native microbiome of the nematode Caenorhabditis elegans: gateway to a new host-microbiome model. BMC Biol. 14, 1–16 (2016).
Samuel, B. S., Rowedder, H., Braendle, C., Félix, M.-A. & Ruvkun, G. Caenorhabditis elegans responses to bacteria from its natural habitats. Proc. Natl Acad. Sci. U. S. A. 113, E3941–E3949 (2016).
Berg, M. et al. Assembly of the Caenorhabditis elegans gut microbiota from diverse soil microbial environments. ISME J 10, 1998–2009 (2016).
Berg, M., Zhou, X. Y. & Shapira, M. Host-specific functional significance of Caenorhabditis gut commensals. Front. Microbiol. 7, 1–9 (2016).
Hoffman, C. L., Lalsiamthara, J. & Aballay, A. Host mucin is exploited by Pseudomonas aeruginosa to provide monosaccharides required for a successful infection. mBio 11, 1–15 (2020).
Pryor, R. et al. Host-microbe-drug-nutrient screen identifies bacterial effectors of metformin therapy. Cell 178, 1299–1312.e29 (2019).
Scott, T. A. et al. Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans. Cell 169, 442–456.e18 (2017).
Han, B. et al. Microbial genetic composition tunes host longevity. Cell 169, 1249–1262.e13 (2017).
Govindan, J. A., Jayamani, E. & Ruvkun, G. ROS-based lethality of Caenorhabditis elegans mitochondrial electron transport mutants grown on Escherichia coli siderophore iron release mutants. Proc. Natl Acad. Sci. U. S. A. 116, 21651–21658 (2019).
Maynard, C., Cummings, I., Green, J. & Weinkove, D. A bacterial route for folic acid supplementation. BMC Biol. 16, 67 (2018).
Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).
Van Opijnen, T. & Camilli, A. Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. Nat. Rev. Microbiol. 11, 435–442 (2013).
Lodish, H. et al. Constructing DNA libraries with λ phage and other cloning vectors. Molecular Cell Biology. Edn. 4 (W.H. Freeman, New York, NY, USA, 2000).
Warnhoff, K. & Ruvkun, G. Molybdenum cofactor transfer from bacteria to nematode mediates sulfite detoxification. Nat. Chem. Biol. 15, 480–488 (2019).
Kitagawa, M. et al. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res 12, 291–299 (2005).
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462–467 (2019).
Sifri, C. D., Begun, J., Ausubel, F. M. & Calderwood, S. B. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 71, 2208–2217 (2003).
Irazoqui, J. E. et al. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog. 6, e1000982 (2010).
Kaletsky, R. et al. C. elegans interprets bacterial non-coding RNAs to learn pathogenic avoidance. Nature 566, 445–451 (2020).
Kirienko, N. V., Cezairliyan, B. O., Ausubel, F. M. & Powell, J. R. Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans. In (eds. Filloux, A. & Ramos, J.-L.) 653–669 (Springer, New York, NY, USA, 2014).
Dirksen, P. et al. CeMbio—The Caenorhabditis elegans microbiome resource. G3 10, 3025–3039 (2020).
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
Fisher, C. K. & Mehta, P. Identifying keystone species in the human gut microbiome from metagenomic timeseries using sparse linear regression. PLoS One 9, e102451 (2014).
Heintz-Buschart, A. & Wilmes, P. Human gut microbiome: function matters. Trends Microbiol 26, 563–574 (2018).
Costea, P. I. et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3, 8–16 (2018).
Qi, B., Kniazeva, M. & Han, M. A vitamin-B2-sensing mechanism that regulates gut protease activity to impact animal’s food behavior and growth. Elife 6, 1–19 (2017).
Virk, B. et al. Folate acts in E. coli to accelerate C. elegans aging independently of bacterial biosynthesis. Cell Rep 14, 1611–1620 (2016).
Watson, E. et al. Metabolic network rewiring of propionate flux compensates vitamin B12 deficiency in C. elegans. Elife 5, 1–21 (2016).
Watson, E. et al. Interspecies systems biology uncovers metabolites affecting C. elegans gene expression and life history traits. Cell 156, 759–770 (2014).
Zhang, J. et al. A delicate balance between bacterial iron and reactive oxygen species supports optimal C. elegans development. Cell Host Microbe 26, 400–411.e3 (2019).
Schiffer, J. A. et al. Caenorhabditis elegans processes sensory information to choose between freeloading and self-defense strategies. Elife 9, 1–29 (2020).
Donato, V. et al. Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway. Nat. Commun. 8, 14332 (2017).
Gusarov, I. et al. Bacterial nitric oxide extends the lifespan of C. elegans. Cell 152, 818–830 (2013).
Gruber, J. & Kennedy, B. K. Microbiome and longevity: gut microbes send signals to host mitochondria. Cell 169, 1168–1169 (2017).
Hartsough, L. A. et al. Optogenetic control of gut bacterial metabolism to promote longevity. Elife 9, e56849 (2020).
Shin, M.-G. et al. Bacteria-derived metabolite, methylglyoxal, modulates the longevity of C. elegans through TORC2/SGK-1/DAF-16 signaling. Proc. Natl Acad. Sci. U. S. A. 117, 17142–17150 (2020).
Virk, B. et al. Excessive folate synthesis limits lifespan in the C. elegans: E. coli aging model. BMC Biol. 10, 67 (2012).
Saiki, R. et al. Altered bacterial metabolism, not coenzyme Q content, is responsible for the lifespan extension in Caenorhabditis elegans fed an Escherichia coli diet lacking coenzyme Q. Aging Cell 7, 291–304 (2008).
Larsen, P. L. Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q. Science 295, 120–123 (2002).
Lin, C.-C. C. J. & Wang, M. C. Microbial metabolites regulate host lipid metabolism through NR5A-Hedgehog signalling. Nat. Cell Biol. 19, 550–557 (2017).
Kumar, A. et al. Caenorhabditis elegans: a model to understand host–microbe interactions. Cell. Mol. Life Sci. 77, 1229–1249 (2020).
Goya, M. E. et al. Probiotic Bacillus subtilis protects against α-synuclein aggregation in C. elegans. Cell Rep. 30, 367–380.e7 (2020).
Urrutia, A. et al. Bacterially produced metabolites protect C. elegans neurons from degeneration. PLoS Biol. 18, e3000638 (2020).
Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167, 1469–1480.e12 (2016).
O’Donnell, M. P., Fox, B. W., Chao, P.-H., Schroeder, F. C. & Sengupta, P. A neurotransmitter produced by gut bacteria modulates host sensory behaviour. Nature 583, 415–420 (2020).
Kissoyan, K. A. B. B. et al. Natural C. elegans microbiota protects against infection via production of a cyclic lipopeptide of the viscosin group. Curr. Biol. 29, 1030–1037.e5 (2019).
Montalvo-Katz, S., Huang, H., Appel, M. D., Berg, M. & Shapira, M. Association with soil bacteria enhances p38-dependent infection resistance in Caenorhabditis elegans. Infect. Immun. 81, 514–520 (2013).
Smolentseva, O. et al. Mechanism of biofilm-mediated stress resistance and lifespan extension in C. elegans. Sci. Rep. 7, 7137 (2017).
Kim, Y. & Mylonakis, E. Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances Gram-positive immune responses. Infect. Immun. 80, 2500–2508 (2012).
Liu, Y., Samuel, B. S., Breen, P. C. & Ruvkun, G. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 508, 406–410 (2014).
Bana, B. & Cabreiro, F. The microbiome and aging. Annu. Rev. Genet. 53, 239–261 (2019).
Watson, E., MacNeil, L. T., Arda, H. E., Zhu, L. J. & Walhout, A. J. M. Integration of metabolic and gene regulatory networks modulates the C. elegans dietary response. Cell 153, 253–266 (2013).
Essmann, C. L. et al. Mechanical properties measured by atomic force microscopy define health biomarkers in ageing C. elegans. Nat. Commun. 11, 1043 (2020).
Patel, D. S., Xu, N. & Lu, H. Digging deeper: methodologies for high-content phenotyping in Caenorhabditis elegans. Lab Anim. (NY) 48, 207–216 (2019).
Kaletta, T. & Hengartner, M. O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5, 387–399 (2006).
Nance, J. & Frøkjær-Jensen, C. The Caenorhabditis elegans transgenic toolbox. Genetics 212, 959–990 (2019).
Dickinson, D. J. & Goldstein, B. CRISPR-based methods for Caenorhabditis elegans genome engineering. Genetics 202, 885–901 (2016).
Evans, T. Transformation and microinjection. (April 6, 2006) WormBook (ed. The C. elegans Research Community) http://www.wormbook.org/chapters/www_transformationmicroinjection/transformationmicroinjection.html (2006).
Merritt, C. et al. Transgenic solutions for the germline. (February 8, 2010) WormBook (ed. The C. elegans Research Community) 1–21 http://www.wormbook.org/chapters/www_transgenic/transgenic.html (2010).
Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71–94 (1974).
Kutscher, L. M., Shaham, S. Forward and reverse mutagenesis in C. elegans. (January 17, 2014) WormBook (ed. The C. elegans Research Community) 1–26 http://www.wormbook.org/chapters/www_frmutagenesis/frmutagenesis.html (2014).
Lehrbach, N. J., Ji, F. & Sadreyev, R. Next-generation sequencing for identification of EMS-induced mutations in Caenorhabditis elegans. Curr. Protoc. Mol. Biol. 117, 7.29.1–7.29.12 (2017).
Thompson, O. et al. The million mutation project: a new approach to genetics in Caenorhabditis elegans. Genome Res 23, 1749–1762 (2013).
Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231–237 (2003).
Melo, J. A. & Ruvkun, G. Inactivation of conserved C. elegans genes engages pathogen- and xenobiotic-associated defenses. Cell 149, 452–466 (2012).
Hunt-Newbury, R. et al. High-throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol. 5, e237 (2007).
Burton, N. O. et al. Cysteine synthases CYSL-1 and CYSL-2 mediate C. elegans heritable adaptation to P. vranovensis infection. Nat. Commun. 11, 1741 (2020).
Kirienko, K., Revtovich, A. & Kirienko, N. A high-content, phenotypic screen identifies fluorouridine as an inhibitor of pyoverdine biosynthesis and Pseudomonas aeruginosa virulence. mSphere 1, e00217-16 (2016).
Mylonakis, E., Ausubel, F. M., Perfect, J. R., Heitman, J. & Calderwood, S. B. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl Acad. Sci. U. S. A. 99, 15675–15680 (2002).
Tan, M.-W. W., Mahajan-Miklos, S. & Ausubel, F. M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl Acad. Sci. U. S. A. 96, 715–720 (1999).
Benedetto, A. et al. New label‐free automated survival assays reveal unexpected stress resistance patterns during C. elegans aging. Aging Cell 18, 1–10 (2019).
Chi, C. et al. Nucleotide levels regulate germline proliferation through modulating GLP-1/Notch signaling in C. elegans. Genes Dev 30, 307–320 (2016).
Rendueles, O. & Ghigo, J.-M. Mechanisms of competition in biofilm communities. Microbiol. Spectr. 3, 1–18 (2015).
Ding, S. S., Schumacher, L. J., Javer, A. E., Endres, R. G. & Brown, A. E. X. Shared behavioral mechanisms underlie C. elegans aggregation and swarming. Elife 8, 1–32 (2019).
Le, K. N. et al. An automated platform to monitor long-term behavior and healthspan in Caenorhabditis elegans under precise environmental control. Commun. Biol 3, 297 (2020).
Pulak, R. Techniques for analysis, sorting, and dispensing of C. elegans on the COPASTM flow-sorting system. In C. elegans: Methods and Applications Vol. 351 (ed. Strange, K.) 275–286 (Humana Press, Totowa, NJ, USA, 2006).
Churgin, M. A. & Fang-Yen, C. An imaging system for C. elegans behavior. In C. elegans: Methods and Applications Edn. 2 Vol. 1327 (eds. Biron, D. & Haspel, G.) 199–207 (Humana Press, Totowa, NJ, USA, 2015).
Stroustrup, N. et al. The Caenorhabditis elegans lifespan machine. Nat. Methods 10, 665–670 (2013).
Yemini, E. I. & Brown, A. E. X. Tracking single C. elegans using a USB microscope on a motorized stage. In C. elegans: Methods and Applications Edn. 2 Vol. 1327 (eds. Biron, D. & Haspel, G.) 181–197 (Humana Press, Totowa, NJ, USA, 2015).
Koopman, M. et al. Assessing motor-related phenotypes of Caenorhabditis elegans with the wide field-of-view nematode tracking platform. Nat. Protoc. 15, 2071–2106 (2020).
Swierczek, N. A., Giles, A. C., Rankin, C. H. & Kerr, R. A. High-throughput behavioral analysis in C. elegans. Nat. Methods 8, 592–598 (2011).
Restif, C. et al. CeleST: computer vision software for quantitative analysis of C. elegans swim behavior reveals novel features of locomotion. PLoS Comput. Biol. 10, e1003702 (2014).
Ramot, D., Johnson, B. E., Berry, T. L., Carnell, L. & Goodman, M. B. The parallel Worm Tracker: a platform for measuring average speed and drug-induced paralysis in nematodes. PLoS One 3, e2208 (2008).
Zhang, W. B. et al. Extended twilight among isogenic C. elegans causes a disproportionate scaling between lifespan and health. Cell Syst 3, 333–345.e4 (2016).
Banse, S. A., Blue, B. W., Robinson, K. J., Jarrett, C. M. & Phillips, P. C. The Stress-Chip: a microfluidic platform for stress analysis in Caenorhabditis elegans. PLoS One 14, e0216283 (2019).
Baris Atakan, H., Alkanat, T., Cornaglia, M., Trouillon, R. & Gijs, M. A. M. Automated phenotyping of Caenorhabditis elegans embryos with a high-throughput-screening microfluidic platform. Microsystems Nanoeng 6, 24 (2020).
Chung, K., Crane, M. M. & Lu, H. Automated on-chip rapid microscopy, phenotyping and sorting of C. elegans. Nat. Methods 5, 637–643 (2008).
Mondal, S. et al. Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model. Nat. Commun. 7, 13023 (2016).
Cermak, N. et al. Whole-organism behavioral profiling reveals a role for dopamine in state-dependent motor program coupling in C. elegans. Elife 9, 1–34 (2020).
Hernando-Rodríguez, B. et al. Combined flow cytometry and high-throughput image analysis for the study of essential genes in Caenorhabditis elegans. BMC Biol. 16, 36 (2018).
Li, X. et al. Systems properties and spatiotemporal regulation of cell position variability during embryogenesis. Cell Rep 26, 313–321.e7 (2019).
Wang, Q. et al. Host and microbiome multi-omics integration: applications and methodologies. Biophys. Rev. 11, 55–65 (2019).
Yang, J. H. et al. A white-box machine learning approach for revealing antibiotic mechanisms of action. Cell 177, 1649–1661.e9 (2019).
Bochner, B. R. Phenotype microArrays for high-throughput phenotypic testing and assay of gene function. Genome Res 11, 1246–1255 (2001).
Zimmermann, J. et al. The functional repertoire contained within the native microbiota of the model nematode Caenorhabditis elegans. ISME J 14, 26–38 (2020).
Freed, N. E. Creation of a dense transposon insertion library using bacterial conjugation in enterobacterial strains such as Escherichia coli or Shigella flexneri. J. Vis. Exp. (127), 56216 (2017).
van Opijnen, T., Bodi, K. L. & Camilli, A. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat. Methods 6, 767–772 (2009).
Kwon, Y. M., Ricke, S. C. & Mandal, R. K. Transposon sequencing: methods and expanding applications. Appl. Microbiol. Biotechnol. 100, 31–43 (2016).
Price, M. N. et al. Mutant phenotypes for thousands of bacterial genes of unknown function. Nature 557, 503–509 (2018).
Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006).
Govindan, J. A., Jayamani, E., Zhang, X., Mylonakis, E. & Ruvkun, G. Dialogue between E. coli free radical pathways and the mitochondria of C. elegans. Proc. Natl Acad. Sci. U. S. A. 112, 12456–12461 (2015).
Matos, R. C. et al. D-Alanylation of teichoic acids contributes to Lactobacillus plantarum-mediated Drosophila growth during chronic undernutrition. Nat. Microbiol. 2, 1635–1647 (2017).
Brooks, J. F. et al. Global discovery of colonization determinants in the squid symbiont Vibrio fischeri. Proc. Natl Acad. Sci. U. S. A. 111, 17284–17289 (2014).
Goodman, A. L. et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6, 279–289 (2009).
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363, eaat993 (2019).
García-González, A. P. et al. Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics. Cell 169, 431–441.e8 (2017).
Koo, B. M. et al. Construction and analysis of two genome-scale deletion libraries for Bacillus subtilis. Cell Syst. 4, 291–305.e7 (2017).
Chan, J. P. et al. Using bacterial transcriptomics to investigate targets of host-bacterial interactions in Caenorhabditis elegans. Sci. Rep. 9, 5545 (2019).
Johnson, E. L. et al. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat. Commun. 11, 2471 (2020).
Rutter, J. W. et al. Detecting changes in the Caenorhabditis elegans intestinal environment using an engineered bacterial biosensor. ACS Synth. Biol. 8, 2620–2628 (2019).
Ding, S. S., Romenskyy, M., Sarkisyan, K. S. & Brown, A. E. X. Measuring Caenorhabditis elegans spatial foraging and food intake using bioluminescent bacteria. Genetics 214, 577–587 (2020).
Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
Westman, E. L. et al. Bacterial inactivation of the anticancer drug doxorubicin. Chem. Biol. 19, 1255–1264 (2012).
Yan, A. et al. Transformation of the anticancer drug doxorubicin in the human gut microbiome. ACS Infect. Dis 4, 68–76 (2018).
Javdan, B. et al. Personalized mapping of drug metabolism by the human gut microbiome. Cell 7, 1661–1679.e22 (2020).
Willing, B. P., Russell, S. L. & Finlay, B. B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 9, 233–243 (2011).
van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict the bioavailability of levodopa, the primary treatment in Parkinson’s disease. Nat. Commun. 31, 1–31 (2018).
Fijlstra, M. et al. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support. Care Cancer 23, 1513–1522 (2015).
Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831–835 (2010).
Pryor, R., Martinez-Martinez, D., Quintaneiro, L. & Cabreiro, F. The role of the microbiome in drug response. Annu. Rev. Pharmacol. Toxicol. 60, 417–435 (2020).
Leffler, D. A. & Lamont, J. T. Clostridium difficile infection. N. Engl. J. Med. 372, 1539–1548 (2015).
Ke, W. et al. Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion. Nat. Commun. 11, 2587 (2020).
Barabási, A.-L., Menichetti, G. & Loscalzo, J. The unmapped chemical complexity of our diet. Nat. Food 1, 33–37 (2020).
Cabreiro, F. et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153, 228–239 (2013).
Cabreiro, F. Metformin joins forces with microbes. Cell Host Microbe 19, 1–3 (2016).
Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).
Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850–858 (2017).
Acknowledgements
We are grateful to Helena Cochemé (MRC London Institute of Medical Sciences) for feedback on the manuscript and to Jennifer van der Laan (Institute of Clinical Sciences, Imperial College London) for assistance with the draft of the figures. F.C. acknowledges funding from the Wellcome Trust/Royal Society (102532/Z/12/Z and 102531/Z/13/A) and Medical Research Council (MC-A654-5QC80).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Lab Animal thanks Katja Dierking, Marina Ezcurra and François Leulier for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Backes, C., Martinez-Martinez, D. & Cabreiro, F. C. elegans: A biosensor for host–microbe interactions. Lab Anim 50, 127–135 (2021). https://doi.org/10.1038/s41684-021-00724-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-021-00724-z
This article is cited by
-
Immunological pathogenesis of Bovine E. coli infection in a model of C. elegans
BMC Microbiology (2022)